Buying The Firm That Makes Hepatitis C Drugs Could Save The U.S. Money

Researchers make major brain repair discovery in fight against Multiple Sclerosis 
March 22, 2017
Exercise reduces death from breast cancer relapse by 40 per cent
March 22, 2017
Show all

Buying The Firm That Makes Hepatitis C Drugs Could Save The U.S. Money

If the government purchased a hepatitis C medication manufacturer, it could save money in the long run.

David Higginbotham contracted hepatitis C more than 35 years ago. He’d like to rid his body of the virus, but Colorado’s Medicaid program says he’s not sick enough to justify the cost.

And he’s not alone.

Since 2013, when Gilead Sciences Inc. released Sovaldi, the first medication that can reliably cure hepatitis C, health insurers and state Medicaid programs have been coming up with ways to limit access to it and a sister drug, Harvoni, because they’re priced so high — more than $80,000 for a 12-week course of Sovaldi at the outset.

Both drugs are produced by Gilead, and their price has dropped some, as competitors have hit the market, but Higginbotham still hasn’t been able to get the cure.

Gilead isn’t the only company that produces expensive drugs. Prices for prescription medications for various conditions have been rising faster than inflation for years.

President Donald Trump says the pharmaceutical industry is “getting away with murder,” and he’s vowed to do something about it

Read full article: Buying The Firm That Makes Hepatitis C Drugs Could Save The U.S. Money : Shots – Health News : NPR

Read Full Article: Buying The Firm That Makes Hepatitis C Drugs Could Save The U.S. Money : Shots – Health News : NPR

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.